Association of plasma epinephrine level with insulin sensitivity in metabolically healthy but obese individuals

Autonomic Neuroscience: Basic and Clinical

Volumn 167, Issue 1-2, 2012, Pages 66-69

  Dai, Xing Ping ^a   Liu, Zhao Qian ^b   Xu, Lin Yong ^b   Gong, Zhi Cheng ^b   Huang, Qiong ^b   Dong, Min ^b   Huang, Xi ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

Author keywords

Cardiovascular disease; Diabetes mellitus; Epinephrine; Insulin sensitivity; Obesity

Indexed keywords

ADRENALIN; C REACTIVE PROTEIN; CATECHOLAMINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; BODY MASS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN SENSITIVITY; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; SEDENTARY LIFESTYLE; TRIACYLGLYCEROL BLOOD LEVEL;

ABSORPTIOMETRY, PHOTON; AGED; BIOLOGICAL MARKERS; BODY COMPOSITION; BODY MASS INDEX; C-REACTIVE PROTEIN; CATECHOLAMINES; CHOLESTEROL, HDL; EPINEPHRINE; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIPIDS; MIDDLE AGED; OBESITY; POSTMENOPAUSE; REGRESSION ANALYSIS; TRIGLYCERIDES;

EID: 84857194969     PISSN: 15660702     EISSN: 18727484     Source Type: Journal    
DOI: 10.1016/j.autneu.2011.10.006     Document Type: Article

References (27)

1. Begin-Heick N. Beta-adrenergic receptors and G-proteins in the ob/ob mouse. Int. J. Obes. Relat. Metab. Disord. 1996, 20(Suppl. 3):S32-S35.
2. Bonora E., Willeit J., Kiechl S., Oberhollenzer F., Egger G., Bonadonna R., Muggeo M. U-shaped and Jshaped relationships between serum insulin and coronary heart disease in the general population. The Bruneck Study. Diab. Care 1991, 21(2):221-230.
3. Brochu M., Tchernof A., Dionne I.J., Sites C.K., Eltabbakh G.H., Sims E.A., Poehlman E.T. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?. J. Clin. Endocrinol. Metab. 2001, 86:1020-1025.
4. Calle E.E., Rodriguez C., Walker-Thurmond K., Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J. Med. 2003, 348(17):1625-1638.
5. Cannon B., Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol. Rev. 2004, 84(1):277-359.
6. Castle A., Yaspelkis B.B., Kuo C.H., Ivy J.L. Attenuation of insulin resistance by chronic beta2-adrenergic agonist treatment possible muscle specific contributions. Life Sci. 2001, 69(5):599-611.
7. Clutter W.E., Bier D.M., Shah S.D., Cryer P.E. Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. J. Clin. Invest. 1980, 66(1):94-101.
8. Cryer P.E. Adrenaline: a physiological metabolic regulatory hormone in humans?. Int. J. Obes. Relat. Metab. Disord. 1993, 17(Suppl. 3):S43-S46. discussion S68.
9. Eberle D., Clement K., Meyre D., Sahbatou M., Vaxillaire M., Le Gall A., Ferré P., Basdevant A., Froguel P., Foufelle F. SREBF-1 gene polymorphisms are associated with obesity and type 2 diabetes in French obese and diabetic cohorts. Diabetes 2004, 53:2153-2157.
10. Ebstein R.P., Stessman J., Eliakim R., Menczel J. The effect of age on beta-adrenergic function in man: a review. Isr. J. Med. Sci. 1985, 21(3):302-311.
11. Festa A., D'Agostino R., Howard G., Mykkanen L., Tracy R.P., Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000, 102:42-47.
12. Karelis A.D., Faraj M., Bastard J.P., St-Pierre D.H., Brochu M., Prud'homme D., Rabasa-Lhoret R. The metabolically healthy but obese individual presents a favorable inflammation profile. J. Clin. Endocrinol. Metab. 2005, 90(7):4145-4150.
13. Lira V.A., Benton C.R., Yan Z., Bonen A. PGC-1alpha regulation by exercise training and its influences on muscle function and insulin sensitivity. Am. J. Physiol. Endocrinol. Metab. 2010, 299(2):E145-E161.
14. Miura S., Kawanaka K., Kai Y., Tamura M., Goto M., Shiuchi T., Minokoshi Y., Ezaki O. An increase in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to exercise is mediated by beta-adrenergic receptor activation. Endocrinology 2007, 148(7):3441-3448.
15. Romano M., Guagnano M.T., Pacini G., Vigneri S., Falco A., Marinopiccoli M., Manigrasso M.R., Basili S., Davì G. Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women. J. Clin. Endocrinol. Metab. 2003, 88(11):5321-5326.
16. Ruderman N.B., Schneider S.H., Berchtold P. The "metabolically-obese", normal-weight individual. Am. J. Clin. Nutr. 1981, 34(8):1617-1621.
17. Rutledge D.R., Steinberg J.D. Effect of age on lymphocyte beta 2-adrenergic responsiveness. DICP 1991, 25(5):532-538.
18. Samanic C., Chow W.H., Gridley G., Jarvholm B., Fraumeni J.F. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control 2006, 17(7):901-909.
19. Schelbert K.B. Comorbidities of obesity. Prim. Care 2009, 36(2):271-285.
20. Seals D.R., Esler M.D. Human ageing and the sympathoadrenal system. J. Physiol. 2000, 528(Pt 3):407-417.
21. Sharma A.M., Pischon T., Hardt S., Kunz I., Luft F.C. Hypothesis: beta-adrenergic receptor blockers and weight gain: a systematic analysis. Hypertension 2001, 37(2):250-254.
22. Steinberg G.R., Jorgensen S.B. The AMP-activated protein kinase: role in regulation of skeletal muscle metabolism and insulin sensitivity. Mini Rev. Med. Chem. 2007, 7(5):519-526.
23. Succurro E., Marini M.A., Frontoni S., Hribal M.L., Andreozzi F., Lauro R., Perticone F., Sesti G. Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. Obesity (Silver Spring) 2008, 16(8):1881-1886.
24. Ukkola O., Bouchard C. Clustering of metabolic abnormalities in obese individuals: the role of genetic factors. Ann. Med. 2001, 33(2):79-90.
25. Westfall T.C., Westfal D.P. Neurotransmission: the autonomic and somatic motor nervous systems. The Pharmacological Basis of Therapeutics 2010, Macmillan Publishing Co, New York, edn 11/e. L.L. Brunton (Ed.).
26. Wildman R.P., Muntner P., Reynolds K., McGinn A.P., Rajpathak S., Wylie-Rosett J., Sowers M.R. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch. Intern. Med. 2008, 168(15):1617-1624.
27. Ziegler M.G., Milic M., Sun P., Tang C.M., Elayan H., Bao X., Cheung W.W., O'Connor D.T. Endogenous epinephrine protects against obesity induced insulin resistance. Auton. Neurosci. 2011, 162(1-2):32-34.